All cancer types

• For Researchers

Welcome to our new committee chairs

We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs. We welcome two outstanding researchers – Kairbaan Hodivala-Dilke and Simon Boulton – as they join our group of funding committee chairs.

22 November 2022

• For Researchers

Joining the dots: How our new research data strategy will unlock the power of big data

To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help To capitalise on the reams of data produced by cancer researchers we must have a joined up approach - here's how our new strategy will help

7 July 2022

• Health & Medicine

Improving cancer care for the LGBTQIA+ community

LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people. LGBTQIA+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQIA+ people.

26 July 2021

• Health & Medicine

Alcohol linked to more than 740,000 new cancer cases globally in 2020

1 in 25 newly diagnosed cancer cases in the last year may be associated with drinking alcohol, according to a global study published in The Lancet Oncology. 1 in 25 newly diagnosed cancer cases in the last year may be associated with drinking alcohol, according to a global study published in The Lancet Oncology.

14 July 2021

• Health & Medicine

Cancer Research UK spin-out goes public, ready to invest more in precision T cell therapies

Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO). Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million through the closing of its initial public offering (IPO).

18 May 2021

• For Supporters

“Helping to develop the science leaders of the future brings great satisfaction” – Mike Gooley on donating £1m

Trailfinders founder, Mike Gooley CBE, has supported our work for more than 20 years. His latest gift will support the Francis Crick Institute's PhD programme. Trailfinders founder, Mike Gooley CBE, has supported our work for more than 20 years. His latest gift will support the Francis Crick Institute's PhD programme.

23 March 2021

• Charity News

Cancer Research UK launches its new equality, diversity and inclusion strategy

Cancer Research UK has today launched its first charity-wide Equality, Diversity and Inclusion strategy, outlining the charity’s commitments to improve progress Cancer Research UK has today launched its first charity-wide Equality, Diversity and Inclusion strategy, outlining the charity’s commitments to improve progress

29 January 2021

• Science & Technology

Scientists develop approach for exploiting cancer’s dietary demands

Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease. Scientists discover a way to target cancer’s nutritional needs, which could lead to a new way to treat the disease.

13 January 2021

• Health & Medicine

Queues build for GP appointments and cancer tests

GPs report struggling to meet appointment demand and increased waiting times for cancer tests. GPs report struggling to meet appointment demand and increased waiting times for cancer tests.

16 December 2020

• Charity News

Charity CEOs warn of irreparable damage to UK research

A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries. A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries.

13 November 2020